| Farnaz Bararaky, MD | |
|
140 Old Orangeburg Rd, Orangeburg, NY 10962-1157 | |
| (845) 359-1000 | |
| Not Available |
| Full Name | Farnaz Bararaky |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 140 Old Orangeburg Rd, Orangeburg, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114065299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 213545 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Farnaz Bararaky, MD 66 Crystal Hill Drive, Pomona, NY 10970 Ph: (845) 359-1000 | Farnaz Bararaky, MD 140 Old Orangeburg Rd, Orangeburg, NY 10962-1157 Ph: (845) 359-1000 |
News Archive
Now, in new research posted to the preprint server bioRxiv*, scientists use an experimental structure of the Spike RBD domain co-crystallized with part of the ACE2 receptor and several in silico methods to analyze the possible impacts of three amino acid replacements (Spike K417N, E484K, N501Y) concerning ACE2 binding.
Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announced today the availability of digital pathology services in Beijing, China. The services add to Quintiles offerings used in the development of therapies to treat the world's most pressing health issues, including cancer.
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.
› Verified 7 days ago
Dr. Rashid A Mian, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 140 Old Orangeburg Rd, Orangeburg, NY 10962 Phone: 845-680-8412 Fax: 845-680-3255 | |
Dr. Edward Richard Herman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 140 Old Orangeburg Rd, Orangeburg, NY 10962 Phone: 845-680-8308 Fax: 845-680-5580 | |
Anjana Kundu, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 599 Convent Road, Orangeburg, NY 10962 Phone: 845-359-7400 | |
Martine Augustin, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 599 Convent Road, Orangeburg, NY 10962 Phone: 845-359-7400 | |
Dr. Lina Levit Haber, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Rockland Psychiatric Center , Orangeburg Road,, Orangeburg, NY 10962 Phone: 845-680-7868 Fax: 845-680-5591 | |
Mehnaz Waseem, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 140 Old Orangeburg Rd, Orangeburg, NY 10962 Phone: 845-359-1000 |